ARCHIVES

“Recalcitrant” Cancers? Committee Rewrite Of Pancreatic Bill Raises New Questions

This article is from The Cancer Letter archive.

Vol. 38 No. 34 | September 14, 2012

Download PDF Visit The Full Archive

Related Articles

Pitt Criticizes NCI Stance On Repayment For Fraud Trials

September 9, 1994

FDA Approves Silicone Gel Breast Implants, Requires 10 Years Of Patient Follow-Up

November 24, 2006

Pharmaceutical Industry: IVAX Official Broder Objects To Orphan Drug Policies of FDA

May 9, 1997

At Least 25 CCOP Applicants Score High Enough To Virtually Assure Funding; Geography An Issue

May 13, 1983

Also Weber returns to M.D. Anderson.

August 8, 2003

Drasga and Einhorn Respond to Single Payer Proposal Rebuttal

February 14, 2014